Meralgia paresthetica.
Chalk C, Namiranian D.
Handb Clin Neurol. 2024;201:195-201. doi: 10.1016/B978-0-323-90108-6.00013-2.
Diabetic Amyotrophy.
Diaz LA, Gupta V.
2023 Aug 14. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Autoimmune diabetic neuropathy.
Krendel DA, Zacharias A, Younger DS.
Neurol Clin. 1997 Nov;15(4):959-71. doi: 10.1016/s0733-8619(05)70358-3.
Meralgia Paresthetica: Relevance, Diagnosis, and Treatment.
Scholz C, Hohenhaus M, Pedro MT, Uerschels AK, Dengler NF.
Dtsch Arztebl Int. 2023 Sep 29;120(39):655-661. doi: 10.3238/arztebl.m2023.0170.
[Diabetic neuropathy--a clinical review].
Nøkleby K, Berg TJ.
Tidsskr Nor Laegeforen. 2005 Jun 16;125(12):1646-9.
Meralgia paresthetica.
Kaiser R.
Rozhl Chir. 2018 Spring;97(6):286-290.
The natural history of diabetic femoral neuropathy.
Coppack SW, Watkins PJ.
Q J Med. 1991 Apr;79(288):307-13.
Immunotherapy for diabetic amyotrophy.
Chan YC, Lo YL, Chan ES.
Cochrane Database Syst Rev. 2017 Jul 26;7(7):CD006521. doi: 10.1002/14651858.CD006521.pub4.
Muscone ameliorates diabetic peripheral neuropathy through activating AKT/mTOR signalling pathway.
Dong J, Li H, Bai Y, Wu C.
J Pharm Pharmacol. 2019 Nov;71(11):1706-1713. doi: 10.1111/jphp.13157. Epub 2019 Aug 29.
Decompressive surgery of lower limbs for symmetrical diabetic peripheral neuropathy.
Chaudhry V, Russell J, Belzberg A.
Cochrane Database Syst Rev. 2008 Jul 16;2008(3):CD006152. doi: 10.1002/14651858.CD006152.pub2.
